WELCOME TO Q-MED
|
Q-Med is a rapidly growing and profitable biotechnology/medical device company that primarily develops, manufactures, markets and sells medical implants. Most of the products are based on the company's patented technology, NASHA™, for the production of stabilized non-animal hyaluronic acid.
The company today has more than 700 co-workers in 20 countries, with approximately 500 at the company's head office and production facility in Uppsala.
Q-Med had sales of 1,318 MSEK during 2007. Q-Med AB is listed in the Mid Cap segment of the OMX Nordic Exchange in Stockholm.
|
|
|
Extraordinary General Meeting of Q-Med AB
|
Shareholders of Q-Med AB are hereby covened to an Extraordinary General Meeting on Wednesday February 4, 2009 at 3 p.m. on Q-Med's premises. Entrance from Fyrisvallsgatan 5, Uppsala
Notice
Register Form »
|
|
|
|
|
|
|
Q-Med’s office will be closed the following days between Christmas and New Year:
Wednesday December 24
Thursday December 25
Friday December 26
Wednesday December 31
Thursday January 1
Friday January 2
Monday January 5
Tuesday January 6
|
|
|
|
|
IMCAS, International Master Course on Aging Skin, 8-11 January in Paris
|
Q-Med will present the latest products and treatment techniques in several workshops, lectures and seminars.
Read more about IMCAS
|
|
|
|
|
|
|
|
QMED 05/01/2009 17:10:19
2.27% 0.60 sek, Vol: 43 299
Last: 27.00 sek
High: 28.00 sek Low: 27.00 sek
 The Q-Med share
|
|
|
|
|
|
|